AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabiliti
SWI Editorial Staff2026-01-29T04:11:59-08:00AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to enhance its capabilities in areas including cell therapies and radioconjugates. With ...







